Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

Two grants from the National Institute of Allergies and Infectious Diseases (NIAID), a four-year $3.2 million award and a 12-month $550,000 administrative supplement, will support innovative research to advance the understanding of how climate change and extreme weather influence HIV-related health outcomes around the world.

MindMed Reports Third Quarter 2024 Financial Results and Business Updates | Psychedelic Invest

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced

November 7, 2024

Lilly again hires from within for CFO post, elevating 23-year company veteran

The world’s most valuable drugmaker has a new finance chief. Lucas Montarce stepped into the chief financial officer role at Eli Lilly, Sign up to

September 10, 2024

California is investing $500M in therapy apps for youth. Advocates fear it won’t pay off.

With little pomp, California launched two apps at the start of the year offering free behavioral health services to youths to help them cope with

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.